Surgical resection offers survival benefits in patients with diffuse low-grade glioma (DLGG) but its association with functional outcomes is uncertain. This systematic review assessed functional outcomes associated with extent of resection (EoR) in adults with DLGG.
We searched Medline, Embase and CENTRAL on the 19th of February 2021 for observational studies reporting functional outcomes after surgical resection for patients aged ≥ 18 years with a new diagnosis of supratentorial DLGG according to any World Health Organization classification of primary brain tumors. The Newcastle–Ottawa Scale (NOS) informed our risk of bias assessments. The proportion of patients returning to work within 12 months entered a random-effects meta-analysis. PROSPERO registration number CRD42021238387.
There were seven eligible moderate to high-quality (NOS > 6) observational studies identified from 1,183 records involving 234 patients with DLGG. Functional outcomes reported included neurocognition (n = 2 studies), performance status (n = 3), quality of life (QoL) (n = 1) and return to work (n = 6). The proportion of patients who returned to work within 12 months of surgery was 84% (95% confidence interval [CI] 50–96%, I-squared = 38%, 5 studies) for gross total resection, 66% (95% CI 14–96%, I2 = 57%, 5 studies) for subtotal resection, and 31% (95% CI 4–82%, I2 = 0%, 4 studies) for partial resection. There was insufficient data on other functional outcomes for quantitative synthesis.
A higher proportion of DLGG patients returned to work following gross total resection compared with those who had a subtotal or partial resection. Further studies with standardized assessments can clarify the association between EoR and different functional outcomes.
Diffuse low-grade glioma (DLGG) is ultimately an incurable disease . It has a predilection for cortical and subcortical white matter tracts fundamental for both motor and speech function [2, 3]. The essence of patient management is an individualized approach employing advanced surgical and oncological methods . Early and maximal surgical resection allows a histological diagnosis to be established and may influence adjuvant therapy [5,6,7]. The extent of resection (EoR), as assessed on volumetric MRI FLAIR sequences is a positive prognosticator on overall survival (OS) and time to tumor progression (TTP) [8, 9]. However, the oncological benefit must be balanced against the risk of functional deficit that lowers the quality of life (QoL) .
Functional outcomes are complex. These outcomes often refer to the ability to carry out activities of daily living and QoL. In people with DLGG, there are additional relevant outcomes. Seizures are common in people with DLGG. Control of seizure, while being a clinical outcome, can have a profound impact on patients’ daily living. Both tumor and cranial surgery can cause cognitive impairments, rendering neurocognition and neuropsychology important functional outcomes. Advances in surgical techniques such as awake surgery and cognitive mapping aim to preserve cognitive functions while enabling maximal resection. Evaluation of modern neurosurgical techniques and novel therapies should include clinical and functional outcomes.
The surgical objective is maximal safe resection, which is associated with better oncological outcomes in DLGG . However, there is uncertainty about the relationship between EoR and functional outcome. This systematic review summarized functional outcomes after surgery for DLGG stratified by EoR.
Materials and methods
This systematic review was registered in PROSPERO (CRD42021238387) and reported according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
This systematic review included all studies of patients aged ≥ 18 years with histologically diagnosed supratentorial DLGG undergoing tumor resection with documented post-operative functional outcome stratified by EoR. Studies featuring any additional interventions not directly affecting EoR were excluded because of the likely bias in patient selection and confounding intervention effects. Exclusion criteria included patients aged < 18 years, high grade glioma, previously treated DLGG and studies that did not provide comparative data on outcomes of interest or otherwise did not meet inclusion criteria. Studies with a sample size of < 10 patients were excluded owing to a potential risk of publication bias.
Information sources and search strategy
MEDLINE, EMBASE and the Cochrane Central Register of Controlled Trials (CENTRAL) were searched on 19/02/2021. The full search strategy is in supplementary materials (Tables 1.1, 1.2 & 1.3). Retrieved search results were combined and uploaded to Covidence – an online web-based platform for systematic review record-keeping and management .
Selection process and data collection
Two reviewers (ME & EB) independently screened each article. Discrepancies during title/abstract screening and full-text eligibility assessment were resolved by discussion between both reviewers and with a senior reviewer (MTCP). Two independent reviewers (ME & EB) extracted data from each included study. Uncertainties were resolved with a senior reviewer (MTCP). For studies that reporting functional outcomes after DLGG surgery but not stratified by EoR, we contacted the corresponding author to seek clarification about the missing or uncertain data. If the corresponding author did not respond after three weeks, inclusion and data extraction decisions would be made in accordance with the available published material.
We collected data on study characteristics, extent of resection and post-operative functional outcomes. Study characteristics included year of publication, country of primary affiliation, study design, duration of patient recruitment and total number of patients recruited. For EoR, we collected the author defined EoR. We recorded both how and when EoR was ascertained. Resections were classified into the following groups: partial resection (PR), subtotal resection (STR), gross total resection (GTR) and supratotal resection (SpTR) according to author-defined subcategories on EoR.
Any objective measurement of a pre-defined postoperative functional outcome stratified by EoR was recorded. Pre-defined post-operative functional outcomes were as follows: performance status, quality of life, neurocognition and time taken to return to work. All included studies were comprehensively searched for time points of outcome acquisition and instruments used to measure each individual outcome (supplementary materials).
Risk of bias assessment
We based our risk of bias assessment on the Newcastle–Ottawa Scale (NOS) for observational studies . The risk of bias within each individual study was independently assessed at the time of data extraction. A senior reviewer was delegated for mediation in the event of disagreement that could not be resolved following discussion between reviewers. Certainty assessment was not applicable to this review. We used funnel plots and Egger’s test to assess publication bias.
Synthesis methods & statistical analysis
We identified studies of moderate to high quality (NOS > 6) for meta-analysis. Where there were four or more studies reporting the same functional outcome at a uniform timepoint, results were summarized in our meta-analysis. If the proportion of patients was reported, then we meta-analyzed the proportions per EoR groups. We planned not to meta-analyze effect size because of anticipated study design heterogeneity. Results for studies included in qualitative analysis were presented in tables. Forest plots were used to illustrate the results of studies included in meta-analysis. For each outcome of interest, the proportion and its respective 95% confidence interval (CI) were calculated using a DerSimonian-Laird random effects model. We used I-squared (I2) and Tau-squared (τ2) statistics to assess heterogeneity. No subgroup analyses were planned to explore study heterogeneity. No sensitivity analyses were planned to assess the robustness of the synthesized results. We used R software version 4.1.2 using packages ‘meta’ (version 5.5–0) and ‘metafor’ (version 3.4–0) for our analyses .
There were 1,183 records retrieved from our search, of which seven eligible studies of 234 adults with DLGG reporting functional outcome after surgical resection were included in this review [15,16,17,18,19,20] (Fig. 1). Study demographics and characteristics are shown (Table 1). One study reported two independent cohorts in one study with outcome separately available for each cohort . The overall risk of bias as measured by the Newcastle–Ottawa Scale in all included studies was low (Table 2).
Of the 234 adults with DLGG included, 146 adults were symptomatic and 88 had an incidental diagnosis. The mean age ranged from 35.7 to 38 years. The ratio of males to females in all studies was 1:0.89. All except one study were conducted in France [15,16,17,18, 20]. Five studies had a prospective design [16,17,18,19,20]. All studies were single-center studies. In 4 of the 7 included studies, EoR was objectively measured on MRI between 48 h and 3 months post operatively [15,16,17, 20]. The remaining three studies did not specify how exactly EoR was measured [18,19,20]. EoR was reported in cm.3 (volumetric analysis) or according to the Berger and Berger-Yordanova classifications [18, 21, 22].
The proportion of surgical resections undertaken across all studies was as follows: 14 partial resections (8.6%), 69 sub-total resections (42.3%), 51 gross total resections (31.3%) and 29 supratotal resections (17.8%). The remaining 71 patients came from a final study which did not specify exact resection proportions for the cohort but did include post-operative QoL data stratified by EoR .
Only one study measured post-operative QoL data stratified by EoR in patients undergoing surgery for DLGG . Three studies recorded individual post-operative Karnofsky performance status (KPS) at three months alongside corresponding EoR data [15,16,17]. Two studies provided individual post-operative neurocognitive assessment data . 6 out of 7 studies reported post-operative return-to-work (RTW) [15,16,17,18, 20].
Quality of life
One study reported QoL following resection of DLGG by EoR . This was a single-center prospective study in India that included 71 consecutive adults with DLGG and reported post-operative QoL before starting adjuvant oncological treatment. Post-operative QoL was evaluated using the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life of Cancer Patients (QLQ-C30) and Brain Cancer Module (QLQ-BN20) questionnaires . The mean EORTC QLQ-C30 global score for all post-operative DLGG patients was 61.9 ± 33.8. For those undergoing partial resection and total excision of DLGG, the mean EORTC QLQ-C30 global score was 66.7 and 58.3 respectively. The type of surgery (biopsy vs. complete resection) had no influence on QoL score in univariable analysis (p = 0.284).
One retrospective case series in France included 24 patients who each underwent awake surgery with intraoperative direct electrical mapping for an insular WHO grade II glioma involving dominant hemisphere . KPS score was evaluated for each patient before surgery. 13 patients did not receive adjuvant treatment at 3 months post op. For the PR group (n = 2), KPS at 3 months after surgery had improved in both patients. For those patients who had a STR (n = 9), all but one had stable or improved KPS at 3 months. Both patients who underwent GTR (n = 2) had improved KPS at 3 months post-operatively.
Another study in France reported a prospective series of 21 patients with incidental DLGG who underwent awake surgery with intraoperative direct electrical mapping for cortical and subcortical eloquent structures . The minimum follow-up duration was 20 months. KPS was evaluated 3 months after surgery. Three months after surgery, all 21 patients’ KPS remained unchanged at 100 regardless of extent of resection.
A third study in France reported a single-center series of 74 patients with incidental DLGG who underwent awake surgery with intraoperative functional mapping through cortical and subcortical direct electrostimulation . Post-operative clinical and radiological data including EoR were prospectively collected. KPS was recorded pre-operatively and at 3 months post-operatively. KPS remained unchanged at 100 in all patients regardless of EoR. The minimum follow-up period for all patients was 12 months.
Only one study reported post-operative neurocognition in patients with DLGG who underwent awake surgery with intraoperative brain mapping . The study ‘s primary objective was to determine if lexical access was correlated with post-operative return to work in DLGG patients. This study consisted of two separate case–control series.
The first retrospective case–control series featured 11 patients who underwent post-operative assessment via a battery of neurocognitive tests. 5 patients had a partial resection whilst 6 patients had a subtotal resection. For language assessment, the picture naming ‘‘DO.80 test’’ was used . This test has two components: naming time (NT) and naming accuracy (NA). The mean NA score was 0.38 for those undergoing PR and 0.69 for the STR group. The mean NT score was − 9.22 for those undergoing PR and − 6.97 in the STR group.
A second prospective case–control series featured 12 patients who performed pre- and post-operative language assessment, using the picture naming ‘‘DO.80 test’’ and had a median follow-up of 9 months. 2 patients had undergone a partial resection, 7 patients had a subtotal resection, and 3 patients underwent gross total resection. Mean NA scores were 0.21, − 2.38 and − 1.09 for the PR, STR and GTR groups respectively. Mean NT scores were − 1.74, − 2.69 and − 2.91 for the PR, STR and GTR groups respectively.
Return to work
Of the seven included studies, six studies reported post-operative RTW data [15,16,17,18, 20]. One study specified that patients who returned to work had the same lexical access as pre-operative function and worked in the same place . Another study reported whether patients returned to full-time or less-than-full time employment . Patients returning to work in all six included studies had intraoperative functional mapping at the time of tumor resection. Meta-analyses of the proportion of patients who returned to work within 12 months of an operation for DLGG was conducted for each subgroup of EoR namely, PR, STR, GTR & SpTR. The proportion of patients who returned to work within 12 months of surgery was 84% (95% confidence interval [CI] 50–96%, I-squared = 38%, 5 studies) for gross total resection, 66% (95% CI 14–96%, I-squared = 57%, 5 studies) for subtotal resection, and 31% (95% CI 4–82%, I-squared 0%, 4 studies) for partial resection (Fig. 2). The proportion of patients who returned to work within 12 months was 69% (95% CI 50–83%, I-squared 0%, 3 studies) in the supratotal resection group. All funnel plots constructed to assess for publication bias across each meta-analysis were symmetric. (Supplementary Material Figs. 3.1, 3.2, 3.3 & 3.4).
Only seven studies reported functional outcomes stratified by EoR in people who had surgical resection for DLGG. Individual studies reported sustained or improved functional outcomes following complete resection, though direct comparison cohorts were lacking. Meta-analysis of six cohorts suggested higher proportion of patients returned to work in those with GTR.
Return to work
The pooled proportion estimate of people returning to work within one year was higher for people who had GTR at 84% compared to those who had STR and PR at 66% and 31%, respectively (Fig. 2). This finding is supportive of the current strategy of maximal safe resection. However, tumor location and tumor volume are likely confounders for the association between EoR and functional outcome. It is difficult to confirm the association between EoR and return-to-work without direct comparative and adjusted analysis. EoR is also a proxy outcome for people returning to a level of functional status that allows them to return to work. This outcome depends on the physical, cognitive, and mental demands of the occupation. The heterogeneous occupations can also introduce a degree of outcome measurement error. Components of an employment can also change, such as place of work, capacity, and role. Few studies provided information on these aspects of return to work. These limitations make the interpretation and clinical translation of results difficult. Objective and standardized measures of functional and neurocognitive status may better inform the association between EoR and functional outcome.
Other functional outcomes
Some studies in this review reported quality of life, performance status and neurocognition in relation to the EoR. Data was insufficient for evidence synthesis by meta-analysis. This lack of data is consistent with another systematic review of functional outcomes after glioma surgery . The systematic review included 160 studies and only 8% and 6% studies reported neurocognition and health reported quality of life, respectively. The authors have initiated a survey of current practices to create a consensus on a standard set of assessments and reporting guidelines . The results are pending especially as the optimal timing of measuring outcomes and battery of tests for each functional outcome domain is unknown.
Outcome ascertainment for functional outcomes is also challenging. While a consensus can agree on the assessment tools, observer bias can affect consistency of assessment results. Patient-reported outcomes are generally regarded as more clinically relevant. However, in patients who may not be able to complete an assessment themselves, family or friends may help answer questions which can introduce a degree of measurement error. As such, there are categories of outcomes: patient-reported outcomes, clinician-reported outcomes, observer-reported outcomes, and task-based outcomes. The optimal functional outcome assessment should incorporate elements from all these categories informed by public and patient involvement.
Strengths and limitations
This systematic review provided a benchmark of functional outcomes stratified by EoR following resective surgery for DLGG. Findings can inform study design of future clinical studies. We were able to meta-analyze results from six moderate to high quality studies to provide estimates of return-to-work within one year.
Only return-to-work had sufficient studies to enter meta-analysis. We were not able to summarize other functional outcomes. Results available from the included studies did not allow examination of the possible interaction between tumor location and EoR on outcomes. Differentiating association of outcomes with tumor location and EoR would require larger cohorts for specific analysis with interaction terms. Taking the absolute numbers for meta-analyses rather than the adjusted effect size from studies make our analyses prone to the effects of confounding. However, none of these studies provided adjusted effect sizes. Our results here provide the best estimate available based on existing evidence. With the updates of the 2021 WHO classification of brain tumors, findings in this review may not apply to all the molecularly defined low-grade gliomas. Future studies need to report detailed clinical features and molecular characteristics to be relevant.
Functional ability is an important outcome alongside progression-free and overall survival. This systematic review showed that few studies have directly assessed the association between EoR and functional outcomes. Though there was a suggestion that higher EoR is associated with a higher chance of returning to work within 12 months, direct comparative studies were lacking. Future studies evaluating novel surgical strategies should incorporate a clinically relevant comparison group and prospectively assess traditional outcomes and functional abilities.
All datasets generated during and/or analyzed in the current study are available in the medRxiv repository; https://www.medrxiv.org/content/10.1101/2022.09.25.22280331v1
Berger MS, Hervey-Jumper S, Wick W (2016) Astrocytic gliomas WHO grades II and III. Handb Clin Neurol 134:345–360. https://doi.org/10.1016/B978-0-12-802997-8.00021-9
Sanai N, Berger MS (2018) Surgical oncology for gliomas: the state of the art. Nat Rev Clin Oncol 15:112–125. https://doi.org/10.1038/nrclinonc.2017.171
Wirsching H-G, Galanis E, Weller M (2016) Glioblastoma. Handb Clin Neurol 134:381–397. https://doi.org/10.1016/B978-0-12-802997-8.00023-2
Van Den Bent MJ, Bromberg JEC, Buckner J (2016) Chapter 22 - Low-grade and anaplastic oligodendroglioma. In: Berger MS, Weller M (eds) Handbook of Clinical Neurology. Elsevier, pp 361–380
Nabors LB, Portnow J, Ahluwalia M et al (2020) Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 18:1537–1570. https://doi.org/10.6004/jnccn.2020.0052
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood | Nature Reviews Clinical Oncology. https://www.nature.com/articles/s41571-020-00447-z. Accessed 30 Jul 2022
Wang W, Hu Y, Lu P et al (2014) Evaluation of the diagnostic performance of magnetic resonance spectroscopy in brain tumors: a systematic review and meta-analysis. PLoS ONE 9:e112577. https://doi.org/10.1371/journal.pone.0112577
Jakola AS, Myrmel KS, Kloster R et al (2012) Comparison of a strategy favoring early surgical resection vs a strategy favoring watchful waiting in low-grade gliomas. JAMA 308:1881–1888. https://doi.org/10.1001/jama.2012.12807
Ius T, Isola M, Budai R et al (2012) Low-grade glioma surgery in eloquent areas: volumetric analysis of extent of resection and its impact on overall survival. A single-institution experience in 190 patients: clinical article. J Neurosurg 117:1039–1052. https://doi.org/10.3171/2012.8.JNS12393
Duffau H, Mandonnet E (2013) The “onco-functional balance” in surgery for diffuse low-grade glioma: integrating the extent of resection with quality of life. Acta Neurochir (Wien) 155:951–957. https://doi.org/10.1007/s00701-013-1653-9
Brown TJ, Bota DA, van Den Bent MJ et al (2019) Management of low-grade glioma: a systematic review and meta-analysis. Neurooncol Pract 6:249–258. https://doi.org/10.1093/nop/npy034
Covidence - Better systematic review management. https://www.covidence.org/. Accessed 2 May 2021
Wells G, Shea B, O’Connell D, et al (2000) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses
R Core Team (2021) R: A language and environment for statistical computing.
Duffau H, Moritz-Gasser S, Gatignol P (2009) Functional outcome after language mapping for insular World Health Organization Grade II gliomas in the dominant hemisphere: experience with 24 patients. Neurosurg Focus 27:E7. https://doi.org/10.3171/2009.5.FOCUS0938
de Lima GL, O, Duffau H, (2015) Is there a risk of seizures in “preventive” awake surgery for incidental diffuse low-grade gliomas? J Neurosurg 122:1397–1405. https://doi.org/10.3171/2014.9.JNS141396
Ng S, Herbet G, Moritz-Gasser S, Duffau H (2020) Return to work following surgery for incidental diffuse low-grade glioma: a prospective series with 74 patients. Neurosurgery 87:720–729. https://doi.org/10.1093/NEUROS/NYZ513
Moritz-Gasser S, Herbet G, Maldonado IL, Duffau H (2012) Lexical access speed is significantly correlated with the return to professional activities after awake surgery for low-grade gliomas. J Neurooncol 107:633–641. https://doi.org/10.1007/s11060-011-0789-9
Budrukkar A, Jalali R, Dutta D et al (2009) Prospective assessment of quality of life in adult patients with primary brain tumors in routine neurooncology practice. J Neurooncol 95:413–419. https://doi.org/10.1007/s11060-009-9939-8
Muto J, Dezamis E, Rigaux-Viode O et al (2018) Functional-based resection does not worsen quality of life in patients with a diffuse low-grade glioma involving eloquent brain regions: a prospective cohort study. World Neurosurg 113:e200–e212. https://doi.org/10.1016/j.wneu.2018.01.213
Berger MS, Deliganis AV, Dobbins J, Keles GE (1994) The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer 74:1784–1791
Yordanova YN, Moritz-Gasser S, Duffau H (2011) Awake surgery for WHO grade II gliomas within “noneloquent” areas in the left dominant hemisphere: Toward a “supratotal” resection - Clinical article. J Neurosurg 115:232–239. https://doi.org/10.3171/2011.3.JNS101333
Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376. https://doi.org/10.1093/jnci/85.5.365
Metz M, Metz-Lutz M, Kremin H, et al (1991) Standardisation d’un test de denomination orale : controle des effects de l’age, du sexe et du niveau de scolarite chez des sujets adultes normaux. undefined
De Witt Hamer PC, De Witt Hamer PC, Klein M et al (2021) Functional outcomes and health-related quality of life following glioma surgery. Neurosurgery 88:720–732. https://doi.org/10.1093/neuros/nyaa365
Findings from this review were presented at the XVII World Congress of Neurosurgery (WFNS 2022) Meeting held in Bogotá, Colombia from the 13th to the 18th of March 2022.
This research received no specific funding from any agency in the public, commercial, or not-for-profit domains. MTCP was supported by a Cancer Research UK Brain Tumour Centre of Excellence Award (C157/A27589).
Conflict of interest
We have no conflicts of interest to declare regarding the materials, methods or products referred to in this submission. We have no financial disclosures.
This is a systematic review and does not require authorization from an ethical committee.
This research did not involve humans, and no informed consent was required.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Below is the link to the electronic supplementary material.
About this article
Cite this article
Elsheikh, M., Bridgman, E., Lavrador, J.P. et al. Association of extent of resection and functional outcomes in diffuse low-grade glioma: systematic review & meta-analysis. J Neurooncol (2022). https://doi.org/10.1007/s11060-022-04192-4
- Low-grade glioma
- Extent of resection
- Functional outcome
- Quality of life
- Return to work